FIORENTINO, MICHELANGELO
 Distribuzione geografica
Continente #
NA - Nord America 16.614
AS - Asia 12.903
EU - Europa 10.557
AF - Africa 969
SA - Sud America 922
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 6
Totale 41.997
Nazione #
US - Stati Uniti d'America 16.418
SG - Singapore 4.394
CN - Cina 3.622
GB - Regno Unito 2.402
IT - Italia 2.150
VN - Vietnam 2.111
DE - Germania 1.541
SE - Svezia 1.148
HK - Hong Kong 1.119
IN - India 716
BR - Brasile 681
RU - Federazione Russa 628
IE - Irlanda 493
FR - Francia 425
NL - Olanda 413
KR - Corea 344
FI - Finlandia 264
ZA - Sudafrica 233
TG - Togo 229
CI - Costa d'Avorio 222
UA - Ucraina 204
EE - Estonia 183
CH - Svizzera 180
SC - Seychelles 149
JO - Giordania 129
JP - Giappone 123
AR - Argentina 118
AT - Austria 118
CA - Canada 110
BG - Bulgaria 100
ID - Indonesia 82
NG - Nigeria 76
BE - Belgio 70
PL - Polonia 63
MX - Messico 54
ES - Italia 40
IR - Iran 39
EC - Ecuador 34
TR - Turchia 33
CL - Cile 25
BD - Bangladesh 23
PY - Paraguay 21
AU - Australia 20
GR - Grecia 20
PK - Pakistan 18
UZ - Uzbekistan 18
HR - Croazia 17
TH - Thailandia 17
CO - Colombia 16
PH - Filippine 16
LB - Libano 15
RO - Romania 15
IQ - Iraq 14
LT - Lituania 14
MY - Malesia 14
DK - Danimarca 12
EG - Egitto 12
PT - Portogallo 12
VE - Venezuela 11
CZ - Repubblica Ceca 10
KE - Kenya 10
MA - Marocco 10
AZ - Azerbaigian 9
IL - Israele 9
AE - Emirati Arabi Uniti 8
DO - Repubblica Dominicana 8
TT - Trinidad e Tobago 8
PE - Perù 7
UY - Uruguay 7
NO - Norvegia 6
LV - Lettonia 5
NP - Nepal 5
SA - Arabia Saudita 5
TW - Taiwan 5
DZ - Algeria 4
EU - Europa 4
LU - Lussemburgo 4
NA - Namibia 4
NZ - Nuova Zelanda 4
AL - Albania 3
BZ - Belize 3
PA - Panama 3
SN - Senegal 3
TN - Tunisia 3
AM - Armenia 2
BW - Botswana 2
BY - Bielorussia 2
FK - Isole Falkland (Malvinas) 2
GH - Ghana 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MD - Moldavia 2
ME - Montenegro 2
MK - Macedonia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
Totale 41.967
Città #
Singapore 2.817
Southend 2.120
Ashburn 1.893
Fairfield 1.785
Chandler 1.304
Hong Kong 1.105
Woodbridge 858
Seattle 835
Wilmington 820
Houston 809
Hefei 775
Princeton 650
Bologna 649
Cambridge 635
Santa Clara 626
Beijing 601
Ann Arbor 590
Dong Ket 529
Dublin 488
Boardman 445
Seoul 341
Ho Chi Minh City 294
Los Angeles 254
Hanoi 241
Berlin 237
Lomé 229
Abidjan 222
Westminster 220
Dallas 213
Nanjing 192
Helsinki 175
Redmond 174
Padova 173
Bern 158
New York 153
Redondo Beach 152
Amman 129
Milan 129
San Diego 129
Buffalo 125
Jinan 109
Tokyo 106
Saint Petersburg 104
Munich 101
Sofia 100
Shenyang 97
Turin 87
Bremen 86
São Paulo 79
Hebei 75
Abeokuta 72
Bengaluru 71
Changsha 71
Frankfurt am Main 71
Tianjin 71
Vienna 69
Brussels 65
Nanchang 63
Redwood City 63
Jacksonville 62
Chicago 61
Lappeenranta 61
Falls Church 57
Guangzhou 55
Shanghai 54
Des Moines 53
Nuremberg 52
Rome 52
Dearborn 51
Jakarta 48
Florence 47
Medford 46
Amsterdam 45
Toronto 41
Hangzhou 40
Warsaw 39
Olalla 37
London 36
Falkenstein 35
Haiphong 32
Jiaxing 32
Norwalk 32
Düsseldorf 31
Phoenix 31
San Francisco 31
Naples 30
Zhengzhou 30
Bühl 29
Krefeld 29
Brooklyn 28
Moscow 28
Turku 27
Yubileyny 27
Paris 26
Montreal 24
Taiyuan 23
Tongling 23
Wuhan 23
Xi'an 23
Fuzhou 22
Totale 27.387
Nome #
A retrospective study to reduce prostate biopsy cores by a real time interactive tool 317
11-C-choline PET/CT imaging for localization of recurrent prostate cancer 263
Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience 237
Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer 233
BRCA1 p.His1673del is a pathogenic mutation associated with a predominant ovarian cancer phenotype 230
Gonadal tumors in koi carp (cyprinus carpio koi): immunohistochemical approach through tissue microarray technique. 222
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 216
Accuracy of [11C] Choline positron emission tomography/computed tomography in preoperative staging in patients with bladder cancer referred to radical cistectomy: comparison with conventional computed tomography 214
Real-time Augmented Reality Three-dimensional Guided Robotic Radical Prostatectomy: Preliminary Experience and Evaluation of the Impact on Surgical Planning 213
Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease. 210
BRAF V600E Status and Stimulated Thyroglobulin at Ablation Time Increase Prognostic Value of American Thyroid Association Classification Systems for Persistent Disease in Differentiated Thyroid Carcinoma 210
An Apparent Diffusion Coefficient-based machine learning model can improve Prostate Cancer detection in the grey area of the PI-RADS 3 category: a single-centre experience 207
A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor. 207
Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST. 207
A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutations. 206
454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples 203
Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance. 198
Clinical significance of BRAF mutation in thyroid papillary cancer 193
BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients 193
Circulating tumor cells in genitourinary tumors 191
Accuracy of endorectal Magnetic Resonance Imaging (MRI) and Dynamic Contrast-Enhanced-MRI (DCE-MRI) in the preoperative local staging of prostate cancer. 190
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 187
Which patients with clinical localized renal mass would achieve the trifecta after partial nephrectomy? The impact of surgical technique 185
Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis 184
Transverse prostate maximum sectional area can predict clinically significant prostate cancer in PI-RADS 3 lesions at multiparametric magnetic resonance imaging 183
A histopathologic screening method for rational use of organs from prostate-specific antigen-positive multiorgan donors: the Italian Emilia-Romagna Region experience 182
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 182
Complete pathological response after chemo-radiation in anaplastic thyroid cancer: A report of two cases 181
18F-FACBC PET/CT FOR NODAL STAGING IN HIGH RISK PROSTATE CANCER: PRELIMINARY DIAGNOSTIC ACCURACY ANALYSIS 180
Genomic profiles of primary and metastatic esophageal adenocarcinoma identified via digital sorting of pure cell populations: Results from a case report 178
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and midterm follow-up 177
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 177
Genomic allelotyping for distinction of recurrent and de novo hepatocellular carcinoma after orthotopic liver transplantation 175
Application of a fluorescent PCR method for molecular diagnosis of posttransplant lymphoproliferative disorders on routine tissue sections. 174
PATOLOGIA - Fondamenti Clinicopatologici in medicina Edizione Italiana a cura di Anna Gasperi-Campani e Walter F. Grigioni 174
Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene. 173
MRI DISPLAYS THE PROSTATIC CANCER ANATOMY AND IMPROVES THE BUNDLES MANAGEMENT BEFORE ROBOT ASSISTED RADICAL PROSTATECTOMY 170
Cutaneous Melanoma with "Paradoxical" p16 Hyper-expression: Molecular and Immunohistochemical Analysis of an Exceedingly Rare Entity with a Focus on Regulator Molecules of the Cell Cycle 169
H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma 169
Clinical management of a pituitary gland metastasis from clear cell renal cell carcinoma. 169
The biopsy Gleason score 3+4 in a single core does not necessarily reflect an unfavourable pathological disease after radical prostatectomy in comparison with biopsy Gleason score 3+3: looking for larger selection criteria for active surveillance candidates 169
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 168
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC 168
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial) 168
A RARE CASE OF GIANT CYSTIC CHONDROID HAMARTOMA OF THE LUNG PRESENTING WITH LEFT SIDE PNEUMOTHORAX. 166
Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST 165
Compa rison of 18F-fluciclovine PET/CT with 11 C-Choline PET/CT for nodal staging in prostate cancer: a prospective study 165
Fibrotic Adhesive Toxic-fat (F.A.T.): the association of fibrotic and adhesive perirenal fat with peri-operative outcomes of robot-assisted par tial nephrectomy (RAPN) 164
Pathological post-mortem findings in lungs infected with SARS-CoV-2 163
Multiparametric magnetic resonance imaging for the differential diagnosis between granulomatous prostatitis and prostate cancer: a literature review to an intriguing diagnostic challenge 162
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 160
LEIOMIOSARCOMA PRIMARIO DEL TESTICOLO: CASO CLINICO 160
Slug/β-Catenin–Dependent Proinflammatory Phenotype in Hypoxic Breast Cancer Stem Cells 160
Incremento dell’attività di RM multiparametrica della prostata: esperienza di un centro a elevato volume di attività 160
Vitamin A deficiency due to selective eating as a cause of blindness in a high-income setting 159
Pembrolizumab in the treatment of metastatic non-small cell lung cancer: A review of current evidence 158
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. 156
Clinical significance of ROS1 5’ deletions in non-small cell lung cancer 155
KIT, NRAS, and BRAF mutations in nail apparatus melanoma. 154
Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer 154
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism 154
The positive impact of virtual microscopy on histopathology education: a comparative, student-centered study 151
Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors 151
BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia 151
Validation of the immunohistochemical expression of programmed death ligand 1 (PD-L1) on cytological smears in advanced non small cell lung cancer 150
Co-alteration of c-Met and ROS1 in Advanced NSCLC: ROS1 Wins 150
MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report 150
Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells 149
Nodal Occult Metastases in Intermediate- and High-Risk Prostate Cancer Patients Detected Using Serial Section, Immunohistochemistry, and Real-Time Reverse Transcriptase Polymerase Chain Reaction: Prospective Evaluation With Matched-Pair Analysis. 149
Frozen section analysis of unusual small testicular tumor masses: report of 3 cases 148
Histological and immunohistochemical characterization of 17 gonadal tumours in koi carp (Cyprinus carpio koi) 148
The Use of Augmented Reality to Guide the Intraoperative Frozen Section During Robot-assisted Radical Prostatectomy 148
BRAF and MLH1 Analysis Algorithm for the Evaluation of Lynch Syndrome Risk in Colorectal Carcinoma Patients: Evidence-Based Data from the Analysis of 100 Consecutive Cases 147
Estrogen Receptors and Melanoma: A Review 147
Liver transplantations with donors aged 60 years and above: the low liver damage strategy 146
Expanding the criteria of organ procurement from donors with prostate cancer: the application of the new Italian guidelines. 145
The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma 143
Immune checkpoint inhibitors for metastatic bladder cancer 143
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC 143
Insights into the impact of chromosome 3p mutations in advanced renal cell carcinoma treated with immune-based combinations or targeted therapy: A single-center experience 142
Computer-based detection of colorectal serrated lesions: Digital flatness, a novel metric designed for whole-slide images 142
REDUCING THE NUMBER OF PROSTATE BIOPSY CORES USING A REAL-TIME TOOL 142
Influence of K-ras status and anti-tumour treatments on complications due to colorectal self-expandable metallic stents: A retrospective multicentre study 141
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy 140
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer 140
Patterns of positive surgical margins after open radical prostatectomy and their association with clinical recurrence 140
Liquid biopsies in urological cancers: what we need to know before starting using them 140
PO.8 COELIAC DISEASE MISDIAGNOSIS IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY 140
DETECTION OF NODAL MICRO-METASTASES WITH SERIAL SECTION, IMMUNOHISTOCHEMISTRY AND REAL TIME POLYMERASE CHAIN REACTION IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER PATIENTS SUBMITTED TO RADICAL PROSTATECTOMY WITH EXTENDED PELVIC LYMPH NODE DISSECTION: A PERSPECTIVE STUDY 140
Beyond multiparametric MRI and towards radiomics to detect prostate cancer: A machine learning model to predict clinically significant lesions 138
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer 138
Real-time quantitative assay for routine testing of HCV RNA in formalin-fixed, paraffin-embedded liver samples. 138
Adequacy of endosonography-derived samples from peribronchial or periesophageal intrapulmonary lesions for the molecular profiling of lung cancer 138
Heterogeneity in the colorectal primary tumor and the synchronous resected liver metastases prior to and after treatment with an anti-EGFR monoclonal antibody 137
THE VALUE OF HISTOLOGICAL REVISION OF BIOPSY CORES IN PATIENTS SUITABLE FOR ACTIVE SURVEILLANCE: COMPARISON WITH SURGICAL SPECIMENS AFTER RADICAL PROSTATECTOMY AND CLINICAL FOLLOW-UP 137
Broad spectrum mutational analysis of chromophobe renal cell carcinoma using next-generation sequencing 137
The role of MRI in the detection of local recurrence: Added value of multiparametric approach and Signal Intensity/Time Curve analysis 136
KRAS and BRAF mutational status as selective criteria for targeted therapy in cholangiocarcinoma. 136
The Prognostic Impact of Tumor Size on Cancer-Specific and Overall Survival Among Patients With Pathologic T3a Renal Cell Carcinoma 136
Identification of SDHA (subunit A of the succinate dehydrogenase) mutations in KIT/PDGFRA WT gastrointestinal stromal tumors (GISTs). 136
Totale 16.890
Categoria #
all - tutte 133.067
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.067


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.543 0 0 0 0 0 155 94 194 426 190 164 1.320
2021/20225.544 562 159 305 379 483 283 176 430 280 286 1.379 822
2022/20235.978 580 896 312 711 450 433 223 349 1.051 174 435 364
2023/20242.150 225 358 145 205 139 334 115 105 175 144 119 86
2024/20257.970 330 1.349 789 538 1.076 422 540 271 149 552 440 1.514
2025/20269.222 1.578 1.835 1.871 1.456 1.943 539 0 0 0 0 0 0
Totale 43.023